AMPH

Amphastar Pharmaceuticals
AMPH

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.22B
EV
$1.63B
Shares Outstanding
47.30M
Beta
0.76

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$32.40
P/E 2025E
8.27x
P/Revenue 2025E
1.69x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Amphastar Pharmaceuticals, Inc.

gainify
AMPH

Amphastar Pharmaceuticals, Inc.

AMPH

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatmen...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Zhang, Yongfeng

Employees

2,028

IPO Date

2014-06-25

Headquarters

11570 6th Street, Rancho Cucamonga, California, 91730, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.